Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Lancet ; 390(10111): 2503-2515, 2017 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-28705460

RESUMEN

In 2015, approximately half a billion people had disabling hearing loss, about 6·8% of the world's population. These numbers are substantially higher than estimates published before 2013, and point to the growing importance of hearing loss and global hearing health care. In this Review, we describe the burden of hearing loss and offer our and others' recommendations for halting and then reversing the continuing increases in this burden. Low-cost possibilities exist for prevention of hearing loss, as do unprecedented opportunities to reduce the generally high treatment costs. These possibilities and opportunities could and should be exploited. Additionally, a comprehensive worldwide initiative like VISION 2020 but for hearing could provide a focus for support and also enable and facilitate the increased efforts that are needed to reduce the burden. Success would produce major personal and societal gains, including gains that would help to fulfil the "healthy lives" and "disability inclusive" goals in the UN's new 2030 Agenda for Sustainable Development.


Asunto(s)
Pérdida Auditiva/terapia , Salud Global , Pérdida Auditiva/epidemiología , Pérdida Auditiva/prevención & control , Humanos
4.
J Appl Lab Med ; 8(6): 1017-1027, 2023 11 02.
Artículo en Inglés | MEDLINE | ID: mdl-37902472

RESUMEN

BACKGROUND: The National Basketball Association (NBA) suspended operations in response to the COVID-19 pandemic in March 2020. To safely complete the 2019-20 season, the NBA created a closed campus in Orlando, Florida, known as the NBA "Bubble." More than 5000 individuals lived, worked, and played basketball at a time of high local prevalence of SARS-CoV-2. METHODS: Stringent protocols governed campus life to protect NBA and support personnel from contracting COVID-19. Participants quarantined before departure and upon arrival. Medical and social protocols required that participants remain on campus, test regularly, physically distance, mask, use hand hygiene, and more. Cleaning, disinfection, and air filtration was enhanced. Campus residents were screened daily and confirmed cases of COVID-19 were investigated. RESULTS: In the Bubble population, 148 043 COVID-19 reverse transcriptase PCR (RT-PCR) tests were performed across approximately 5000 individuals; Orlando had a 4% to 15% test positivity rate in this timeframe. There were 44 COVID-19 cases diagnosed either among persons during arrival quarantine or in non-team personnel while working on campus after testing but before receipt of a positive result. No cases of COVID-19 were identified among NBA players or NBA team staff living in the Bubble once cleared from quarantine. CONCLUSIONS: Drivers of success included the requirement for players and team staff to reside and remain on campus, well-trained compliance monitors, unified communication, layers of protection between teams and the outside, activation of high-quality laboratory diagnostics, and available mental health services. An emphasis on data management, evidence-based decision-making, and the willingness to evolve protocols were instrumental to successful operations. These lessons hold broad applicability for future pandemic preparedness efforts.


Asunto(s)
Baloncesto , COVID-19 , Humanos , Pandemias , Estaciones del Año , SARS-CoV-2
6.
Lancet ; 372(9637): 475-88, 2008 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-18687461

RESUMEN

The HIV/AIDS pandemic has become part of the contemporary global landscape. Few predicted its effect on mortality and morbidity or its devastating social and economic consequences, particularly in sub-Saharan Africa. Successful responses have addressed sensitive social factors surrounding HIV prevention, such as sexual behaviour, drug use, and gender equalities, countered stigma and discrimination, and mobilised affected communities; but such responses have been few and far between. Only in recent years has the international response to HIV prevention gathered momentum, mainly due to the availability of treatment with antiretroviral drugs, the recognition that the pandemic has both development and security implications, and a substantial increase in financial resources brought about by new funders and funding mechanisms. We now require an urgent and revitalised global movement for HIV prevention that supports a combination of behavioural, structural, and biomedical approaches and is based on scientifically derived evidence and the wisdom and ownership of communities.


Asunto(s)
Servicios de Salud Comunitaria/tendencias , Países en Desarrollo , Salud Global , Infecciones por VIH/prevención & control , Prioridades en Salud , Servicios de Salud Comunitaria/organización & administración , Femenino , Infecciones por VIH/epidemiología , Humanos , Incidencia , Masculino
7.
Conn Med ; 73(6): 325-31, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19637661

RESUMEN

Acute HIV infection (AHI) is the earliest stage of HIV disease, when plasma HIV viremia, but not HIV antibodies, can be detected. Acute HIV infection often presents as a nonspecific viral syndrome. However, its diagnosis, which enables linkage to early medical care and limits further HIV transmission, is seldom made. We describe the experience of Yale's Center for Interdisciplinary Research on AIDS with AHI diagnosis in Connecticut, as a participating center in the National Institute of Mental Health Multisite AHI Study. We sought to identify AHI cases by clinical referrals and by screening for AHI at two substance abuse care facilities and an STD clinic. We identified one case by referral and one through screening of 590 persons. Screening for AHI is feasible and probably cost effective. Primary care providers should include AHI in the differential diagnosis when patients present with a nonspecific viral syndrome.


Asunto(s)
Infecciones por VIH/diagnóstico , Adolescente , Adulto , Connecticut/epidemiología , Estudios de Factibilidad , Infecciones por VIH/epidemiología , Infecciones por VIH/inmunología , Humanos , Persona de Mediana Edad , Atención Primaria de Salud , Factores de Riesgo , Adulto Joven
8.
Acad Med ; 83(2): 122-7, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18303355

RESUMEN

Duke University and the National University of Singapore (NUS) have partnered to launch a new medical school that brings the American style of postbaccalaureate medical education to Asia. The new institution, called the Duke-NUS Graduate Medical School (GMS) and located in Singapore adjacent to the Singapore General Hospital, admitted its inaugural class of students representing citizens of seven nations in August 2007. The project represents an investment of more than $350 million from three ministries of the Singapore government, and a commitment on Duke's part to provide senior leadership and recruit faculty from Duke, from other international locales, and from within Singapore itself. Graduating students who complete the four-year Duke curriculum will receive an MD degree awarded jointly by Duke and NUS, thereby distinguishing this school from medical education in most Asian institutions that award an MBBS degree after a five-year period of study that follows directly from secondary school. The emphasis of the Duke-NUS GMS is to prepare physician-scientists for academic careers, with plans for 20% of each class to complete a combined MD/PhD degree. This article describes events leading up to this partnership and details of the relationship, including curriculum, organizational structure, milestones, and goals.


Asunto(s)
Educación de Postgrado/organización & administración , Educación de Pregrado en Medicina/organización & administración , Salud Global , Cooperación Internacional , Facultades de Medicina/organización & administración , Humanos , Internet , Modelos Educacionales , North Carolina , Desarrollo de Programa , Singapur
13.
Health Aff (Millwood) ; 31(7): 1380-8, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22778326

RESUMEN

The President's Emergency Plan for AIDS Relief (PEPFAR) has made a major contribution to the reduction of the global HIV/AIDS burden. The program initially focused on rapidly scaling up treatment and prevention services in fifteen low-income countries, then transitioned to an approach that emphasizes sustainability, defined as the capacity to maintain program services after financial, managerial, and technical assistance from the United States and other external donors essentially ceases. Today, PEPFAR continues to expand its HIV prevention, treatment, and care activities while also supporting capacity-building initiatives, coordination efforts, and implementation science. The latter is research focused on improving service delivery, maximizing cost-effectiveness, and achieving public health impact. Recent advances in both scientific knowledge and the provision of prevention, treatment, and care services have bred cautious optimism about greatly reducing the spread of HIV. However, success will require a substantial increase in resources, strengthened health systems, renewed commitment to HIV prevention, and well-financed efforts to develop an effective HIV vaccine.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/terapia , Cooperación Internacional , Síndrome de Inmunodeficiencia Adquirida/prevención & control , África del Sur del Sahara , Urgencias Médicas , Infecciones por VIH/prevención & control , Infecciones por VIH/terapia , Humanos , Objetivos Organizacionales , Evaluación de Programas y Proyectos de Salud , Estados Unidos
14.
Acad Med ; 86(9): 1093-9, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21785305

RESUMEN

Globalization is having a growing impact on health and health care, presenting challenges as well as opportunities for the U.S. health care industry in general and for academic health science systems (AHSSs) in particular. The authors believe that AHSSs must develop long-term strategies that address their future role in global medicine. AHSSs should meet global challenges through planning, engagement, and innovation that combine traditional academic activities with entrepreneurial approaches to health care delivery, research, and education, including international public-private partnerships. The opportunities for U.S.-based AHSSs to be global health care leaders and establish partnerships that improve health locally and globally more than offset the potential financial, organizational, politico-legal, and reputational risks that exist in the global health care arena. By examining recent international activities of leading AHSSs, the authors review the risks and the critical factors for success and discuss external policy shifts in workforce development and accreditation that would further support the growth of global medicine.


Asunto(s)
Centros Médicos Académicos , Atención a la Salud , Internacionalidad , Relaciones Interprofesionales , Educación Médica , Política de Salud , Humanos , Comunicación Interdisciplinaria , Viaje , Estados Unidos
15.
Otol Neurotol ; 31(1): 31-41, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20050266

RESUMEN

BACKGROUND: Hearing loss (HL) and deafness are global issues that affect at least 278 million people worldwide. Two thirds of the people who have HL worldwide live in developing countries. Importantly, it is estimated that 50% of this HL can be prevented. In developing countries, funding for prevention, early detection, and rehabilitative programs is severely limited, and therefore, agencies must compete against priorities to treat life-threatening, pandemic diseases such as human immunodeficiency virus, malaria, and tuberculosis. Delays in diagnosis are common, and social attitudes, local customs, and cultural bias are contributing factors. OBJECTIVE: The purpose of this review is to gain an understanding of the prevalence of HL in the developing world and to focus attention on the growing need for both prevention and effective treatment programs. A second goal is to use this information to suggest priorities and approaches to address these problems worldwide. DATA SOURCES: The data were compiled from a review of the literature on the global impacts of hearing impairment and recently published reports on the prevalence and cause of hearing impairment in developing nations. CONCLUSION: The high prevalence of HL in the developing world is due to a variety of factors, including lack of widespread comprehensive immunization programs and other medical care, and inadequate funds for intervention once HL is identified. International organizations, governments, and nongovernment organizations have many opportunities to prevent and treat HL through cost-effective means.


Asunto(s)
Salud Global , Pérdida Auditiva/epidemiología , Países en Desarrollo , Necesidades y Demandas de Servicios de Salud , Pérdida Auditiva/prevención & control , Pérdida Auditiva/terapia , Humanos , Prevalencia
16.
Am J Public Health ; 92(12): 1905-7, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12453805

RESUMEN

The primary goal of HIV prevention is to prevent as many infections as possible. This requires allocating HIV-prevention resources according to cost effectiveness principles: those activities that prevent more infections per dollar are favored over those that prevent fewer. This is not current practice in the United States, where prevention resources from the federal government to the states flow in proportion to reported AIDS cases. Although such allocations might be considered equitable, more infections could be prevented for the same expenditures were cost-effectiveness principles invoked. The downside of pure cost-effective allocations is that they violate common norms of equity. In this article, we argue for a middle ground that promotes both equity and efficiency in allocating federal HIV-prevention resources.


Asunto(s)
Infecciones por VIH/economía , Infecciones por VIH/prevención & control , Asignación de Recursos para la Atención de Salud/economía , Prevención Primaria/economía , Asignación de Recursos/economía , Síndrome de Inmunodeficiencia Adquirida/economía , Síndrome de Inmunodeficiencia Adquirida/prevención & control , Análisis Costo-Beneficio , Financiación Gubernamental , Infecciones por VIH/epidemiología , Asignación de Recursos para la Atención de Salud/métodos , Investigación sobre Servicios de Salud , Humanos , Evaluación de Resultado en la Atención de Salud , Prevención Primaria/normas , Estados Unidos/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA